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A ribosomal frameshift is required for the synthesis of
an essential component of the yeast telomerase
pathway; this and other findings on telomerases from
many species raise interesting questions regarding the
evolutionary relationship between telomerases and
retrotransposons lacking long terminal repeats.
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The DNA of telomeres, the protein–DNA complexes
present at the ends of linear chromosomes, cannot be
replicated completely by the conventional mechanisms of
DNA replication. This limitation leads to loss of terminal
sequences, a phenomenon termed the ‘end-replication’
problem. In the vast majority of eukaryotes, nuclear chro-
mosomal DNA terminates in a region of G–T/C–A-rich
simple sequences, with the G–T-rich strand proceeding in
a 5′→3′ direction towards the telomere. The enzyme
responsible for the synthesis of these simple telomeric
sequence tracts is the ribonucleoprotein complex telom-
erase, first identified in ciliates [1]. This unusual enzyme
uses a sequence within its RNA component as the tem-
plate for the synthesis of repeats onto the termini of the
G–T-rich strand.
Telomerase has aroused a considerable degree of interest
in recent years because of its presence in a wide variety of
organisms, its novel mode of DNA synthesis and its regu-
lation in vertebrate systems. It is of particular medical
interest that proliferative cells, including germ-line and
self-renewing lineages, contain telomerase activity,
whereas most somatic tissues lack detectable levels of
telomerase activity [2]. A high proportion of tumors
contain telomerase activity, however, leading to the pro-
posal of a relationship between telomerase activation and
oncogenesis. This possibility has been strengthened by
recent studies showing that the ectopic expression of
telomerase prevents senescence in vitro, leading to a phe-
notype similar to cellular immortality, consistent with the
oncogenesis model [3,4].
Based upon its enzymatic properties, telomerase has long
been proposed to be a specialized reverse transcriptase;
data supporting this claim did not emerge until very
recently, however [5]. A major breakthrough was facili-
tated by the purification of telomerase from the hypo-
trichous ciliate Euplotes. The Euplotes telomerase consists
of the telomerase RNA and two proteins, p123 and p43.
Cloning of the gene encoding the p123 subunit revealed
that this protein contained the essential motifs characteris-
tic of reverse transcriptases (Figure 1). The identification
of the Saccharomyces cerevisiae homolog of p123 provided
the opportunity to rigorously test the role of these motifs
in telomerase function [5,6]. 
Previous genetic studies in yeast had identified the telom-
erase RNA component, TLC1, and four proteins
(Est1p–Est4p), that were essential for the maintenance of
telomeric sequences [7–9]. Elimination of any one of
these five factors results in yeast mutants that have identi-
cal phenotypes — a loss of telomeric sequences and a sub-
sequent loss of viability. Epistasis analysis indicated that
all five factors lie in the same genetic pathway [9]. Inter-
estingly, one of these proteins, Est2p, is homologous to
the p123 protein of Euplotes, particularly in the region con-
taining the reverse transcriptase motifs [5,6]. Elegant
mutational analysis of Est2p demonstrated that mutation
of most residues known to be essential for the activity of
other reverse transcriptases resulted in the loss of telom-
eric sequences in vivo and in the abrogation of telomerase
activity (Figure 1). Est2p/p123 is therefore likely to be the
catalytic subunit of telomerase, probably acting through a
similar mechanism as that used by reverse transcriptases.
Interestingly, Est1p, Est3p, and Est4p are not required for
telomerase activity in vitro, even though mutation of any
of these proteins causes the same phenotype of telomeric
loss in vivo as does Est2p loss [10].
Recent studies have identified putative homologs of the
Est2p/p123 protein from several organisms, including
human cells [11–13]. Each of these candidates contain
both a high degree of homology in the reverse transcrip-
tase motifs and an additional telomere-specific (T) motif
[11–13]: higher levels of divergence were observed
outside of these domains. Several lines of evidence
support the idea that the putative human counterpart of
Est2p/p123 (hEst2) represents the bona fide telomerase
catalytic subunit. First, mutations in several hEst2
residues, known to be essential for reverse transcriptase
activity, eliminate telomerase activity [11–13] (Figure 1).
Second, the expression pattern of hEST2 among different
tissues is tightly correlated with telomerase activity
[11,12]. Third, hEst2 co-immunoprecipitates with both
telomerase RNA and telomerase activity [13]. Fourth, co-
expression of telomerase RNA and hEST2 in an in vitro
transcription–translation system generated telomerase
activity [14]: this activity was eliminated by mutations in
the essential conserved motifs. Fifth, expression of the
hEST2 gene in a human cell line containing the telom-
erase RNA but lacking telomerase activity is sufficient to
generate telomerase activity in transient transfection
assays in vivo [14]. The complete resolution of the compo-
sition of human telomerase awaits the in vitro reconstitu-
tion of activity from purified components, however. The
emerging picture of telomerases is therefore that they
contain a set of loosely conserved proteins that are most
highly conserved in the region of the reverse transcriptase
and telomerase-specific motifs.
Two distinct retrotransposons use reverse transcriptases
conserved at the evolutionary level: long terminal repeat
(LTR)-retrotransposons, and non-LTR retrotransposons,
which integrate into the genome in unique ways. Several
investigators have used highly-conserved regions within
reverse transcriptase domains to determine the evolution-
ary relationship of telomerases to other reverse transcrip-
tases [11,15]. The result depends on the manner in which
the evolutionary tree is rooted. In the first case, if the evo-
lutionary tree is rooted in ancestral RNA-dependent RNA
polymerases, non-LTR retrotransposons are likely to be
derived from primordial telomerases. In the second case,
when the tree is rooted in prokaryotic/mitochondrial
retroelements, then telomerases would be predicted to
have arisen from an ancestral non-LTR retrotransposon.
In either interpretation, the data point to an unmistakable
link between the evolution of non-LTR retrotransposons
and telomerase.
A further link has been provided by the studies of Morris
and Lundblad [16] who demonstrated that an essential
component of the yeast telomerase machinery, Est3p,
undergoes a programmed translational frameshift, similar
to that observed in some non-LTR retrotransposons.
Characterization of the EST3 gene revealed a remarkable
finding — the absence of an extended open-reading frame
(ORF). Only two small consecutive out-of-frame ORFs
were identified (Figure 2). Morris and Lundblad noted
that ribosomal frameshifting at the site of a rarely utilized
codon would be expected to produce a 20 kDa protein.
Consistent with this expectation, overexpression of the
putative EST3 transcript yields a 20 kDa protein as well as
a smaller protein of an equivalent size to that predicted
from the upstream ORF sequence. Neither protein shares
any similarity with proteins currently present in the data-
bases. Genetic analyses revealed that both the upstream
and the downstream ORFs were required for the produc-
tion of the full-size products and that replacement of the
rare codon at the site of frameshifting with a more fre-
quently used codon resulted in the absence of the 20 kDa
product. Curiously, expression of a transcript containing
in-frame versions of the two ORFs could fully comple-
ment the est3 null mutation even though the upstream
ORF was not produced. These data indicated that the
20 kDa protein, but not the product from the upstream
ORF, is essential for normal EST3 function. 
Even though Morris and Lundblad [16] find no regula-
tory function for the Est3p frameshift, it seems unlikely
that the conservation of a programmed frameshift is
simply a non-functional evolutionary remnant of a shared
ancestor. Indeed, the rule to date among genes encoding
proteins that control telomere size is that these genes
show a high rate of divergence despite their protein
products serving seemingly similar roles. For example,
R162 Current Biology, Vol 8 No 5
Figure 1
Mutational analysis of reverse transcriptase
regions (1, 2, A, B′, C, D and E) and T motifs
in telomerase. The general organization of the
active-site motifs is shown relative to the
organization of non-LTR retrotransposons and
retroviruses [10]. A cumulative representation
of mutational analysis [5,6,11,13,14]
conducted in yeast (Sc) and human (Hu) cells
of variant residues (v), conserved residues (c,
found in majority of evolutionarily distant
reverse transcriptase motifs), and invariant
residues (i) within and flanking the motifs is
shown. Phenotypes are denoted as follows: x,
significant effect on telomerase activity and/or
telomere length; o, no detectable effect on
telomerase activity or telomere length; –, not
tested. For the mutational analysis, the
following amino acids (single-letter amino acid
code) in Saccharomyces cerevisiae Est2p
were mutated to alanine residues: D530,
D536, D529, Q602, D628, Q632, D647,
Q661, D670, D671, D678, and Q681.
Similarly, the following amino acids in the
human Est2p homolog were mutated to
alanines: F487, F560, F561, Y562, T564,
E565, K626, R631, R688, D712, Y717,
Q833, D868, D897, and G932. The
schematic diagram (not to scale) represents
the relative positions of domains and mutated
residues.
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although the telomerase-associated p80 proteins identi-
fied in ciliate and vertebrate cells have retained their con-
served domains, these proteins are otherwise highly
diverged [17–19]. Nonetheless, both of these p80 proteins
clearly associate with the telomerase complex [13,17–20].
Furthermore, telomere-binding proteins from different
species retain little homology in their primary sequence
except for the presence of a DNA-binding domain related
to that of the Myb family of transcription factors [21–23].
These proteins include the vertebrate telomere-binding
protein TRF1, which has diverged rapidly even among
closely related species [21].
It seems most likely, therefore, that the frameshift repre-
sents an essential function that is either retained through
evolution or regained at various points during evolution.
Given the lack of a detectable function for frameshifting,
however, the programmed frameshift may provide an
advantage over an evolutionary timescale. The presence
of programmed frameshifts in retrotransposons is often
used to decrease the abundance of the frameshifted
product, relative to that of the upstream protein. It may
well be that Est3p is a limiting factor for telomerase activ-
ity in vivo, preventing the promiscuous activity of telom-
erase which, over an evolutionary timescale or in the
presence of extensive DNA damage, may have a severely
deleterious effect. It will be interesting to determine
whether the low abundance of Est3p limits the healing of
broken ends and whether other non-catalytic components
of the telomerase machinery are regulated by frameshifting. 
These links between telomerase and elements of non-
LTR retrotransposons are particularly interesting given
that a small but diverse set of organisms, including
Drosophila and the blue-green algae Chlorella, can compen-
sate for loss of telomeric sequences through the addition
of telomere-specific non-LTR retrotransposons [24,25].
The two best studied examples of these transposons are
the Drosophila HeT-A and TART telomere-specific ele-
ments. Telomerase expression appears to be completely
absent from Drosophila and maintenance of telomere size
depends entirely on the frequent transposition of these
two retrotransposons to chromosomal termini. The HeT-A
element is a non-LTR retrotransposon that produces a
transcript encoding a protein homologous to the retroviral
Gag proteins. Interestingly, a translational frameshift is
required for synthesis of the full-length HeT-A protein
[26] (Figure 2). In contrast, the TART element contains
two discrete ORFs, the first encoding a homolog of the
Gag protein and the second encoding a reverse transcrip-
tase. Non-LTR retrotransposons appear to use the 3′
hydroxyl group of a DNA end as a primer for reverse tran-
scription, making them well suited for telomere-specific
transposition [27].
Although an evolutionary link between non-LTR retro-
transposons and telomerases seems unmistakable, the data
should be interpreted more cautiously when attempting to
correlate the evolutionary history of telomere-specific
retrotransposons with that of telomerases. The complica-
tion of such an approach is the inherent assumption that
only a single means of telomere addition is present in any
organism. A large body of data indicates otherwise,
however, and suggests that multiple means of protecting
the termini from degradation might have co-evolved. For
example, in the yeast S. cerevisiae, a ‘secondary’ pathway
involving recombination can overcome the requirement
for telomerase, allowing continued growth of the popula-
tion [28]. In addition, recent studies have identified a set
of LTR-transposable elements, Ty5, that preferentially
insert into regions adjacent to telomeres, providing a third
potential system for protection of the terminus [29]. 
Similar secondary recombinational pathways have been
found in cells from a multiplicity of organisms, including
humans [30]. Indeed, at least some members of the Lilium
family seem to utilize recombination between LTRs as
the primary mechanism for controlling telomere size [31].
This idea of multiple pathways would also be most consis-
tent with the finding that the structurally distinct HeT-A
and TART elements have a similar end-protection mecha-
nism. Of particular relevance, however, is the recent
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Figure 2
Frameshifting in the translation of yeast EST3 and Drosophila HeT-A
ORFs. The DNA and protein sequence surrounding the site of the
frameshift are shown both before and after programmed ribosomal
frameshifting. EST3 and HeT-A upstream ORFs have +1 and –1
frameshifts, respectively. The stop codons for the uncorrected and
translationally frameshifted Drosophila HeT-A ORFs are 30 amino
acids and 507 amino acids downstream of the frameshift site,
respectively. 
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HeT-A
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observation that Chlorella telomeres seem to have two
active means of telomere maintenance: telomerase-medi-
ated replication and non-LTR retrotransposition [25].
Some chromosome ends in Chlorella contain canonical
telomeric repeats, with the Zepp retrotransposon present
in multiple copies in subtelomeric locations: however, in
at least one telomere, simple-sequence repeats appear to
have been lost altogether, leaving a Zepp retrotransposon
at the extreme terminus. 
The co-evolution of alternative mechanisms for telomere
maintenance would predict that elimination of the telom-
erase pathway would simply uncover a second pathway.
Rather than revealing an evolutionary relationship, the
presence of a limited set of ‘back-up’ mechanisms may
instead be an indicator of the limited mechanisms —
telomerase-mediated replication, transposition, and
recombination — that can be used by the cell for end pro-
tection. In some cases, these secondary processes may
have evolved later than telomerase and possibly indepen-
dently of this ribonucleoprotein complex. The puzzle of
the evolutionary interrelationships among mechanisms for
solving the end-replication problem will provide a unique
challenge for the future. 
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